The Atrium Health Navicent Medical Center is a 637-bed hospital located in Macon, Georgia. Formerly known as The Medical Center of Central Georgia, the hospital is part of the Atrium Health Navicent healthcare system. MCNH is the second largest hospital in Georgia, behind Grady Memorial Hospital in Atlanta.

There are 637 beds in Medical Center of Central Georgia.

During the past decade, Medical Center of Central Georgia conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 61 clinical trials were completed, i.e. on average, 169.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 33 clinical trials were completed. i.e. 825% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Center of Central Georgia" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "Children's Oncology Group" with 27 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored and "Boston Scientific Corporation" with 12 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center of Central Georgia" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NRG Oncology" with 5 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center of Central Georgia" are "Leukemia" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Sarcoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Kidney Cancer" (6 trials). Many other conditions were trialed in "Medical Center of Central Georgia" in a lesser frequency.

Most popular intervention types in "Medical Center of Central Georgia" are "Drug" (99 trials), "Other" (57 trials), "Biological" (47 trials), "Radiation" (24 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (13 trials), "cyclophosphamide" (12 trials), "filgrastim" (11 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center of Central Georgia" are 115 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Center of Central Georgia". undefined are not yet recruiting, 11 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Medical Center of Central Georgia, 2 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center of Central Georgia, 2 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".

Medical Center of Central Georgia has several departments that took part in Clinical trials: "Mercer University, Department of Internal Medicine" - 5 trials